Why the study?
Does candesartan cilexetil microinjection into the RVLM reduce blood pressure and sympathetic nerve discharge in spontaneously hypertensive rats?
Population
Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats
Comparison
Bilateral microinjections of the AT1-receptor… vs Similar microinjections in Wistar-Kyoto (WKY) rats
Design
Preclinical
Authors
Loading...
Central AT1 blockade may reduce sympathetic drive in hypertensive models; leaves open translation to human RVLM therapies.
Does candesartan cilexetil microinjection into the RVLM reduce blood pressure and sympathetic nerve discharge in spontaneously hypertensive rats?
Blockade of AT1-receptors in the RVLM reduces blood pressure and sympathetic nerve discharge in spontaneously hypertensive rats, indicating that Ang II inputs are activated to maintain elevated sympathetic tone in this model.
Andrew M. Allen (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: